Watching Larimar Therapeutics; Traders Circulate Stock Picked By Zacks Under $10 Newsletter

BenzingaNov 7 23:57

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Futu NewsNov 1 20:31 · Ratings

Express News | Larimar Therapeutics Inc : Guggenheim Raises Target Price to $26 From $25

BreakingsOct 31 19:09

Citi Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $14

Futu NewsOct 31 10:33 · Ratings

Larimar Therapeutics | 10-Q: Q3 2024 Earnings Report

SECOct 31 05:07 · Announcements

LifeSci Capital Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $36

Futu NewsOct 31 00:31 · Ratings